Statistics
Publications
3
Citations
73
H-Index
3
Active since
1999
Affiliations
Ludwig Cancer Research(Current)
Rushdi Shakri is an author at Ludwig Cancer Research specializing in oncogenes, cancer pharmacology, and ras signaling pathway.
Publications per year
1999–2000
3
3
Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077.
Anjali Tikoo, Rushdi Shakri, Lisa Connolly et al. · PubMed · 2000 · 27 citations
Medicine, Oncology, Pharmacology +17
The Anti‐RAS Cancer Drug MKT‐077 Is an F‐Actin Cross‐Linker
Hiroshi Maruta, Anjali Tikoo, Rushdi Shakri et al. · Annals of the New York Academy of Sciences · 1999 · 14 citations
Medicine, Cancer Biology, Oncology +11
1–3 of 3